High Purity (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopentyl]-4-phenyl-2-oxazolidinone CAS 189028-93-1 Manufacturer & Supplier

As a leading manufacturer and supplier of specialized pharmaceutical intermediates in China, we offer high-purity (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopentyl]-4-phenyl-2-oxazolidinone (CAS 189028-93-1). This critical compound is essential for the synthesis of ezetimibe, a widely used medication for managing cholesterol levels. Partner with us for reliable sourcing and competitive pricing.

Get a Quote & Sample

Why Choose Our Pharmaceutical Intermediate

Uncompromising Quality Assurance

We adhere to stringent quality control measures at every step, ensuring that our pharmaceutical intermediate meets the highest industry standards. This commitment as a reliable manufacturer provides peace of mind for your critical API synthesis.

Strategic Sourcing & Supply Chain

Leverage our robust supply chain as your dependable supplier. We manage inventory efficiently to guarantee timely delivery and support your production schedules, offering competitive price points for bulk purchases.

Expert Technical Support

Our team of chemists and technical specialists is available to provide in-depth support, assisting with product specifications, application guidance, and troubleshooting for your synthesis needs. Buy with confidence from our expert team.

Core Applications and Industrial Relevance

Ezetimibe Synthesis

This compound is a crucial building block for ezetimibe, a potent inhibitor of cholesterol absorption, making it vital for cardiovascular drug manufacturing. As a key intermediate supplier, we support the production of life-saving medications.

Cholesterol Management Therapies

Its application extends to the broader field of cholesterol-lowering therapies, where precise chemical intermediates are essential for developing effective and safe treatments for hypercholesterolemia.

Chiral Intermediate for API Development

As a complex chiral molecule, it serves as an advanced intermediate in the development of other Active Pharmaceutical Ingredients (APIs) requiring stereospecific synthesis, demonstrating its versatility.

Research & Development

In pharmaceutical R&D, this high-purity intermediate is valuable for exploring novel synthesis routes and developing next-generation lipid-lowering agents. Inquiry for purchase and quotation.